Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Sensitivity of Project: EVO Monitor Cognitive Function Measurements to Methylphenidate and Triazolam in Adults 40-55 Years Old

NCT02822937 is registered in ClinicalTrials.gov with Akili Interactive Labs, Inc. as lead sponsor.

NCT NCT02822937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02822937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Sensitivity of Project: EVO Monitor Cognitive Function Measurements to Methylphenidate and Triazolam in Adults 40-55 Years Old
Lead sponsor
Akili Interactive Labs, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2016
Completion date
November 30, 2016
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy